Zanubrutinib shows durable efficacy in CLL/SLL with 17p deletions, according to 5-year SEQUOIA trial data.

It's time to break the silence around men’s mental and sexual health. True strength is speaking up, seeking support, and ...

Discover fertility options for people with cystic fibrosis. Learn about pregnancy risks, genetic counseling, and reproductive ...

Results from three trials continue to demonstrate the potential of DATROWAY® (datopotamab deruxtecan) in combination with various immunotherapies to improve outcomes in patients with non-small cell ...